AR023151A1 - Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico - Google Patents
Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilicoInfo
- Publication number
- AR023151A1 AR023151A1 ARP000101318A ARP000101318A AR023151A1 AR 023151 A1 AR023151 A1 AR 023151A1 AR P000101318 A ARP000101318 A AR P000101318A AR P000101318 A ARP000101318 A AR P000101318A AR 023151 A1 AR023151 A1 AR 023151A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation containing
- pharmaceutical preparation
- active principle
- acid
- acetilsalicilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Un preparado médico que contiene como principio activo por lo menos una parte de ácido acetilsalicílico para alcanzar, en la sangre de un organismo, elnivel de plasma necesario para combatir los estados de dolor y/o fiebre o para prevenir la trombosis, que se caracteriza por el hecho de que se presenta enforma de administracion transmucosal para la aplicacion bucal de Aspirina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19913731A DE19913731A1 (de) | 1999-03-26 | 1999-03-26 | Medizinische Zubereitung, enthaltend als Wirkstoff zumindest einen Anteil von Acetylsalicylsäure |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023151A1 true AR023151A1 (es) | 2002-09-04 |
Family
ID=7902490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101318A AR023151A1 (es) | 1999-03-26 | 2000-03-24 | Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR023151A1 (es) |
AU (1) | AU3430600A (es) |
DE (1) | DE19913731A1 (es) |
WO (1) | WO2000057884A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3485920A (en) * | 1967-06-12 | 1969-12-23 | Gen Foods Corp | Analgesic compositions of aspirin and pectin |
DE2501548A1 (de) * | 1974-01-25 | 1975-07-31 | Procter & Gamble | Mundbehandlungsmittel |
JPH07553B2 (ja) * | 1985-12-09 | 1995-01-11 | 佐藤製薬株式会社 | フイルム状製剤 |
DE3935550A1 (de) * | 1989-10-25 | 1991-05-02 | Pharmatrans Sanaq Ag | Kaubare oder lutschbare arzneiform, verfahren zu ihrer herstellung und ihre verwendung |
DE4102629A1 (de) * | 1991-01-30 | 1992-08-06 | Bayer Ag | Pharmazeutischer kaugummi mit acetylsalicylsaeure |
DE69521623T2 (de) * | 1994-10-28 | 2002-05-16 | The Procter & Gamble Company, Cincinnati | Zusammensetzung für die stabilisation von zahnprothesen |
-
1999
- 1999-03-26 DE DE19913731A patent/DE19913731A1/de not_active Withdrawn
-
2000
- 2000-03-21 AU AU34306/00A patent/AU3430600A/en not_active Withdrawn
- 2000-03-21 WO PCT/EP2000/002458 patent/WO2000057884A1/de not_active Application Discontinuation
- 2000-03-24 AR ARP000101318A patent/AR023151A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE19913731A1 (de) | 2000-09-28 |
WO2000057884A1 (de) | 2000-10-05 |
AU3430600A (en) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02012792A (es) | Composicion y forma de de dosificacion para liberacion gastrica retardada de alendronato y/u otros bis-fosfonatos. | |
AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
UY26977A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos | |
NO330947B1 (no) | Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand | |
PT1207756E (pt) | Utilizacao de espinosade ou de uma formulacao que compreende espinosade | |
AR240250A1 (es) | Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo. | |
ECSP034883A (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen | |
ATE353009T1 (de) | Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen | |
UY25192A1 (es) | Formulación medicamentosa con liberación controlada de sustancia activa | |
PT1383752E (pt) | 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos | |
AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
BR0014826A (pt) | Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm | |
ES2119748T3 (es) | Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua. | |
ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
AR023151A1 (es) | Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico | |
PT1202956E (pt) | Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo | |
ES2182504T3 (es) | Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento. | |
PA8496801A1 (es) | Complejo farmaceutico | |
AR048138A1 (es) | Formulacion farmaceutica de liberacion controlada | |
PT1242062E (pt) | Gel anidro que compreende nsaid para administracao topica na cavidade oral | |
AR029096A1 (es) | Combinacion de sustancias activas que contiene montirelina y un compuesto de efecto opioide, medicamentos y formulaciones medicamentosas que contienen dicha combinacion y su uso para la preparacion de medicamentos para tratamiento del dolor | |
DE50005282D1 (de) | Medikament sowie aufeinander abgestimmte kombination von medikamenten | |
HN1999000174A (es) | Formulacion medicamentosa acuisa para administracion oral. | |
ATE494239T1 (de) | Vorrichtung zum abgeben von pharmazeutischen produkten | |
CU23150A3 (es) | Formulacion de medicamento con liberacion controlada de sustancia activa |